HBM Healthcare Investments AG (SWX: HBMN)
Finanzas · Mercados de capitales · CH
222,50 CHF
-0,22 % hoy · +7,5 % 1 año
HBM Healthcare Investments AG (SWX: HBMN) opera en la industria de mercados de capitales dentro del sector finanzas. Su valor en bolsa es de 1,74 mil M $.
En los últimos doce meses la acción ha subido un 7,5 % y ha cotizado entre 198,60 y 258,00.
Tweenvest puntúa a HBM Healthcare Investments AG en cuatro factores: calidad 56/100, valor 66/100, dividendo 92/100. Su punto más fuerte es dividendo.
Evolución de la cotización de HBMN
Cifras clave
- Capitalización
- 1,74 mil M $
- Ingresos (últ. 12 m)
- 427,64 M $
- PER
- 4,17
- BPA
- 53,36
- Rent. por dividendo
- 4,04 %
- Beta (5 años)
- 0,76
- Máximo 52 semanas
- 258,00 CHF
- Mínimo 52 semanas
- 198,60 CHF
- Volumen medio (3 m)
- —
- Acciones en circulación
- 6,55 M
- Empleados
- —
- Próximos resultados
- —
Sobre HBM Healthcare Investments AG
HBM Healthcare Investments AG specializes in both direct investments and a fund-of-funds strategy, focusing exclusively on the healthcare sector, encompassing human medicine, pharmaceuticals, biotechnology, diagnostics, and medical technology. Its direct investments target a diverse range of companies, from early-stage startups and various venture and growth phases to mature private enterprises, unlisted emerging firms, and small-cap public entities. The firm also provides capital for company buyouts, growth initiatives, Private Investments in Public Equity (PIPEs), and the spin-off of product lines or departments from larger corporations, as well as the expansion or restructuring of established businesses. Through its fund-of-funds approach, HBM allocates capital to venture capital funds. Initial direct investments are typically made in companies whose primary products are either in clinical development or just prior to that stage. With a global investment mandate, the company emphasizes opportunities in North America, Europe, and the Asia Pacific region. For publicly traded companies, HBM generally prioritizes those that originated within its private investment portfolio. The firm often increases its commitment to portfolio companies through subsequent financing rounds or after their initial public offering. HBM frequently secures a seat on the portfolio company's Board of Directors and may acquire majority stakes. While primarily investing through equity, it also employs various other financial instruments, including convertible bonds, debt securities, structured products, and derivatives. Exits from these investments are typically facilitated through trade sales or initial public offerings.
- ISIN
- CH0012627250
- Fundada en
- 2001
- Cotiza desde
- 14 feb 2008
- Bolsa
- SIX Swiss Exchange
- Divisa
- CHF
Otras empresas de mercados de capitales
| Empresa | Capitalización | Precio | Día |
|---|---|---|---|
| Eaton Vance Tax-Advantaged Global Dividend Income FundNYSE: ETG | 1,75 mil M $ | 22,96 $ | -0,39 % |
| Nanhua Futures Co., Ltd.SHSE: 603093 | 1,75 mil M $ | 12,55 CN¥ | -1,65 % |
| KFin Technologies LimitedNSEI: KFINTECH | 1,74 mil M $ | 950,90 Rs | -1,40 % |
| Nuveen Municipal Value Fund, Inc.NYSE: NUV | 1,74 mil M $ | 8,29 $ | +0,48 % |
| Boursa Kuwait Securities Company K.P.S.C.KWSE: BOURSA | 1,73 mil M $ | 2,69 KD | -1,03 % |
| National Securities Depository LimitedBSE: 544467 | 1,72 mil M $ | 805,65 Rs | +0,97 % |
| I.B.I. Investment House LtdTASE: IBI | 1,72 mil M $ | 393,90 ₪ | -1,87 % |
| Twenty One Capital, Inc.NYSE: XXI | 1,72 mil M $ | 4,95 $ | -1,00 % |